CLARITY (Clinical Assessment of Response in the Treatment of Depression with Daytime Sleepiness Using Solriamfetol) is a Phase 3, double-blind, placebo-controlled, multicenter randomized withdrawal ...
DMT therapy significantly reduced major depressive disorder symptoms in a phase IIa trial. Learn more about this rapid-acting ...
Major depressive disorder (MDD) is a disturbance of mood that may have persistent and long-term consequences impacting patients’ overall level of functioning and quality of life. 1 Historically, ...
Credit: Otsuka. At this time, the product is available to patients for a discounted price of $50; the full price is $200. Rejoyn ™, the first prescription digital therapeutic cleared for the treatment ...
8don MSN
Single dose of a psychedelic drug can rapidly reduce depressive symptoms, clinical trial suggests
A single dose of the psychedelic drug dimethyltryptamine (DMT), given with psychological support, rapidly reduced depressive ...
As the conversation around mental health disorders like depression becomes increasingly normalized, it can also blur the lines between situational feelings of stress, anxiety, and dejection and ...
Researchers develop machine learning tools that screen for co-morbid anxiety disorders and major depressive disorder using acoustic voice signals. The team spoke to participants with and without ...
Mood symptoms alone do not account for the extent of disability associated with MDD. 12 Cognitive impairment, 1 of the 9 core symptoms of MDD (see Table 1), is significantly associated with impaired ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results